Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Abilify will reduce tics (repetitive,
uncontrollable movements or vocalizations) in children and adolescents ages 7-18 with
Tourette's Disorder (TD) or a chronic motor tic disorder (either repetitive, uncontrollable
movements or vocalizations).
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health